Dishman Pharmaceuticals and Chemicals, city-based contract research and manufacturing services (CRAMS) player is reportedly planning to introduce 60 generic active pharmaceutical ingredients (APIs) by the end of 2013-14 financial year. Of this, at least 30 APIs will be launched during FY13, while the remaining will be launched during FY14.
The company has already filed 20 drug master files (DMFs), and another 20 DMFs are in the pipeline. The company’s product portfolio includes antiseptic, anaesthetic, laxative, anti-diabetic, anti-fungal, diuretic, analgesic, anti-ulcer segments.
Dishman Pharmaceuticals and Chemicals is engaged in manufacturing of Bulk API, Intermediates, Specialties and Quats. The company has started production of a range of phase transfer catalysts and quaternary ammonium and phosphonium compounds in 1989.
